Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
114,408,516
-
Shares change
-
+6,704,264
-
Total reported value, excl. options
-
$565,681,944
-
Value change
-
+$2,884,295
-
Put/Call ratio
-
53%
-
Number of buys
-
77
-
Number of sells
-
76
-
Price
-
$4.95
Institutional Holders of OREXIGEN THERAPEUTICS INC - COM (OREX) as of Q2 2015
As of 30 Jun 2015 OREXIGEN THERAPEUTICS INC - COM (OREX) had 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 114,408,516 shares of stock of the company.
Largest 10 holders included FMR LLC, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, SAMLYN CAPITAL, LLC, Partner Fund Management, L.P., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, Foresite Capital Management II, LLC, and CREDIT SUISSE AG/.
This table shows 157 institutional shareholders of the security as of 30 Jun 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.